Home

Fullerton Management Pte Ltd

CIK 1379348 · last filed 2019-10-18

Fullerton Management Pte Ltd is a corporate insider who has filed 18 SEC Form 4 insider transactions across 5 companies since 2009. The most recent filing, for VIR, was dated Oct 18, 2019. Across all open-market trades the lifetime net is −$135.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $120.7M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$120.65M

Companies

5

Total Filings

18

Lifetime Open-Market Net

-$135.12M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
VIR 10%+ Owner 3,333,333 $9.34 $31.13M $50.00M 1 2019-10-18
GH 10%+ Owner 596,012 $150.20 $89.52M $0 1 2018-10-11
PORTOLA PHARMACEUTICALS INC (PTLA) Delisted 10%+ Owner 10,717,136 — — -$161.92M 2 2017-06-05
AMYRIS, INC. (AMRS) Delisted 10%+ Owner 3,302,585 $0.05 $165.1K -$18.35M 10 2017-04-21
Fresh Tracks Therapeutics, Inc. (VICL) Delisted 10%+ Owner 585,096 — — -$4.85M 4 2009-05-22

Recent Filings

18 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2019-10-18 VIR Mixed +27,499,995 $50.00M EDGAR
2018-10-11 GH Conv (C) +6,452,028 $0 EDGAR
2017-06-05 PORTOLA PHARMACEUTICALS INC (PTLA) Delisted Sell (S) −6,800,000 -$233.92M EDGAR
2017-04-21 AMYRIS, INC. (AMRS) Delisted Sell (S) −2,610,052 -$1.44M EDGAR
2017-03-28 AMYRIS, INC. (AMRS) Delisted Sell (S) −516,236 -$249.9K EDGAR
2017-03-16 AMYRIS, INC. (AMRS) Delisted Sell (S) −1,081,496 -$502.2K EDGAR
2017-02-13 AMYRIS, INC. (AMRS) Delisted Sell (S) −1,716,792 -$882.8K EDGAR
2016-12-09 AMYRIS, INC. (AMRS) Delisted Sell (S) −1,142,492 -$922.4K EDGAR
2016-12-05 AMYRIS, INC. (AMRS) Delisted Sell (S) −2,225,184 -$1.86M EDGAR
2016-11-16 AMYRIS, INC. (AMRS) Delisted Sell (S) −2,593,368 -$2.11M EDGAR
Showing 1–10 of 18
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.